Tonix Pharmaceuticals
TNXP
#10306
Rank
โ‚ฌ42.15 M
Marketcap
2,17ย โ‚ฌ
Share price
-6.67%
Change (1 day)
-85.03%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -โ‚ฌ0.14 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ29.1 Million. In 2025 the company made an earning of -โ‚ฌ0.12 Billion a decrease over its 2024 earnings that were of -โ‚ฌ68.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.14 Billion26.45%
2025 -โ‚ฌ0.12 Billion61.37%
2024 -โ‚ฌ68.54 Million-36.5%
2023 -โ‚ฌ0.11 Billion5.61%
2022 -โ‚ฌ0.11 Billion21.43%
2021 -โ‚ฌ84.16 Million82.76%
2020 -โ‚ฌ46.05 Million75.22%
2019 -โ‚ฌ26.28 Million9.52%
2018 -โ‚ฌ24 Million23.63%
2017 -โ‚ฌ19.41 Million-45.36%
2016 -โ‚ฌ35.53 Million-19.09%
2015 -โ‚ฌ43.91 Million74.15%
2014 -โ‚ฌ25.22 Million153.99%
2013 -โ‚ฌ9.93 Million
2011 -โ‚ฌ4.79 Million29538.74%
2010 -โ‚ฌ0.02 Million-42.58%
2009 -โ‚ฌ0.03 Million46.05%
2008 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-โ‚ฌ21.19 Million-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚ฌ32.5 M-121.96%๐Ÿ‡บ๐Ÿ‡ธ USA